Adverum Biotechnologies, Inc.

NasdaqCM:ADVM

Sector

🏥 Health Care

Industries

🧬 Biotechnology

🔬 Clinical Trials

💊 Pharmaceuticals

Location

United States

Market Cap

USD 47.84 M

Share Price

USD 2.29

Avg Daily Volume

267,570

Change (1 day)

-6.53%

Change (1 year)

-66.91%

Change (YTD)

-50.96%

Adverum Biotechnologies, Inc. EBITDA for the year ending December 31, 2024: USD -127.27 M

Adverum Biotechnologies, Inc. EBITDA is USD -127.27 M for the year ending December 31, 2024, a 3.22% change year over year. EBITDA means earnings before interest, taxes, depreciation, and amortization, which measures a company's operating performance by excluding non-operating expenses.

Adverum Biotechnologies, Inc. EBITDA for the year ending December 31, 2023 was USD -123.30 M, a -16.65% change year over year.
Adverum Biotechnologies, Inc. EBITDA for the year ending December 31, 2022 was USD -147.93 M, a 5.00% change year over year.
Adverum Biotechnologies, Inc. EBITDA for the year ending December 31, 2021 was USD -140.90 M, a 25.54% change year over year.
Adverum Biotechnologies, Inc. EBITDA for the year ending December 31, 2020 was USD -112.23 M, a 78.40% change year over year.